Insider Transactions in Q4 2024 at I Teos Therapeutics, Inc. (ITOS)

ITOS Quotes by TradingView

Insider Transaction List (Q4 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Dec 06 2024
David Feltquate Chief Medical Officer
BUY
Grant, award, or other acquisition
Direct
47,000 +50.0%
-
Nov 19 2024
Matthew Gall Chief Financial Officer
BUY
Open market or private purchase
Direct
5,000 +7.1%
$35,000 $7.73 P/Share

Track Institutional and Insider Activities on ITOS

Follow iTeos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

News

Receive news related to iTeos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITOS